Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/05/3073955/0/en/SEED-Therapeutics-Highlights-Breakthrough-Advances-in-Targeted-Protein-Degradation-at-AACR-2025.html
24 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/24/3067294/0/en/SEED-Therapeutics-Reports-Breakthroughs-for-Two-Targeted-Protein-Degradation-Projects-at-AACR-Annual-Meeting-in-Chicago.html
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016234/0/en/SEED-Receives-FDA-Rare-Pediatric-Disease-and-Orphan-Drug-Designations-for-Lead-Oncology-Asset-RBM39-Degrader-and-Enters-Strategic-Transactions-with-New-Investors.html
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016236/0/en/BeyondSpring-Announces-35-4-Million-Sale-of-a-Portion-of-Equity-Interest-in-SEED-Therapeutics-to-Advance-Lead-Asset-Plinabulin-to-Anti-Cancer-Registrational-Studies.html
12 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/12/2945072/0/en/SEED-Therapeutics-Appoints-Eisai-Co-Ltd-s-Dr-Yoshiharu-Mizui-to-Board-of-Directors.html
07 Aug 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/eisai-plants-molecular-glue-seed-15b-biobucks-deal-neuro-oncology
ABOUT THIS PAGE